CYP gene polymorphisms and early menarche

Molecular Genetics and Metabolism

Volumn 74, Issue 4, 2001, Pages 449-457

  Lai, Joe ^a   Vesprini, Danny ^a   Chu, William ^a   Jernström, Helena ^b   Narod, Steven A ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CYP17; CYP1A2; CYP1B1; CYP3A4; Early menarche; Genotype

Indexed keywords

CYTOCHROME P450 17; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; CYTOCHROME P450 3A4; CYTOCHROME P450 ISOENZYME; DNA; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; DNA POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; HUMAN EXPERIMENT; MENARCHE; NORMAL HUMAN; ONSET AGE; PRIORITY JOURNAL; QUESTIONNAIRE;

EID: 0035691747     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.2001.3260     Document Type: Article

References (58)

1. Epidemiologic analysis of breast and gynecologic cancers
2. Menstrual factors and risk of breast cancer
3. Menstrual cycle patterns and the risk of breast disease
4. Exogenous estrogens and other factors in the epidemiology of breast cancer
5. Combined effect of childbearing, menstrual events, and body size on age-specific breast cancer risk
6. Risk factors for breast cancer in women in northern Alberta, Canada, as related to age at diagnosis
7. Risk factors for breast cancer
8. The role of reproductive and menstrual factors in cancer of the breast before and after menopause
9. Menstrual factors and breast cancer risk
10. Do regular ovulatory cycles increase breast cancer risk?
11. Early menarche, a risk factor for breast cancer, indicates early onset of ovulatory cycles
12. Age at menarche, probability of ovulation and breast cancer risk
13. Endocrine characteristics of adolescent menstrual cycles: Impact of early menarche
14. Premenarcheal endocrine changes in relation to age at menarche
15. Age at menarche, urine estrogens and breast cancer risk
16. Some endocrine characteristics of early menarche, a risk factor for breast cancer, are preserved into adulthood
17. Lactation and reproductive histories of breast cancer patients in Boston, 1965-66
18. Menopause and breast cancer risk
19. The putative high activity variant, CYP3A4*1B, predicts the onset of puberty in young girls
20. Human liver microsomal steroid metabolism: Identification of the major microsomal steroid hormone 6 beta-hydroxylase cytochrome P-450 enzyme
21. Steroid hormone hydroxylase specificities of eleven cDNA-expressed human cytochrome P450s
22. Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4
23. Androgen action and the sex accessory tissues
24. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17
25. Sequence analysis and homology modeling suggest that primary congenital glaucoma on 2p21 results from mutations disrupting either the hinge region or the conserved core structures of cytochrome P4501B1
26. Functional significance of a C→A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine
27. Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: Evidence for solvent-induced bends in DNA heteroduplexes
28. Tissue-specific, cyclic adenosine 3′,5′-monophosphate-induced, and phorbol ester-repressed transcription from the human P450c17 promoter in mouse cells
29. Cytochrome P450c17alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations
30. A polymorphism in the CYP17 gene increases the risk of breast cancer
31. CYP17 and breast cancer risk: The polymorphism in the 5′ flanking area of the gene does not influence binding to Sp-1
32. NF-1C, Sp1, and Sp3 are essential for transcription of the human gene for P450c17 (steroid 17alpha-hydroxylase/17,20 lyase) in human adrenal NCI-H295A cells
33. 17 Beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1
34. Functional role of estrogen metabolism in target cells: Review and perspectives
35. Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis?
36. 4-Hydroxylation of estradiol by human uterine myometrium and myoma microsomes: Implications for the mechanism of uterine tumorigenesis
37. Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells
38. Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2
39. Isolation and characterization of the human cytochrome P450 CYP1B1 gene
40. Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: Association of polymorphisms with functional differences in estrogen hydroxylation activity
41. Genetic polymorphism of cytochrome P450-1B1 and risk of breast cancer
42. Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes
43. Molecular mechanisms of estrogen carcinogenesis
44. Lifestyle and nutritional correlates of cytochrome CYP1A2 activity: Inverse associations with plasma lutein and alpha-tocopherol
45. A distribution study of CYP1A2 phenotypes among smokers and non-smokers in a cohort of healthy Caucasian volunteers
46. Effects of dietary broccoli on human in vivo drug metabolizing enzymes: Evaluation of caffeine, oestrone and chlorzoxazone metabolism
47. Dietary and physical determinants of menarche
48. Earlier onset of puberty in girls: Relation to increased body mass index and race
49. Urocytogram, an index of maturity in premature infants
50. The importance of steroid hormones in the pathogenesis of hyperbilirubinemia and neonatal jaundice
51. Human preterm birth is associated with systemic and local changes in progesterone/17 beta-estradiol ratios
52. Intrauterine environment and breast cancer risk in women: A population-based study
53. Evidence of prenatal influences on breast cancer risk
54. Plasma steroid assay in the assessment of foetoplacental function
55. Study of the metabolic clearance rate of dehydroisoandrosterone sulfate in pregnancy
56. Toxemia of pregnancy: Assessment of fetal distress by urinary estriol and circulating human placental lactogen and alpha-fetoprotein levels
57. Fetal growth and placental function assessed by urinary estriol excretion before the onset of pre-eclampsia
58. Serum levels of unconjugated and total oestrogens and dehydroepiandrosterone, progesterone and urinary oestriol excretion in pre-eclampsia